Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/sctm.20-0239 http://scihub22266oqcxt.onion/10.1002/sctm.20-0239 32808462!7461462!32808462     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32808462&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Stem+Cells+Transl+Med 2020 ; 9 (12): 1488-1494 Nephropedia Template TP {{tp|p=32808462|t=2020. Mesenchymal stromal cells for sepsis and septic shock: Lessons for treatment of COVID-19 |pdf=|usr=}}{{32808462}} gab.com Text Mesenchymal stromal cells for sepsis and septic shock: Lessons for treatment of COVID-19 JO: Stem Cells Transl Med http://www.kidney.de/pget.php?&tw=1&pmid=32808462 #FOAvip Sepsis is defined as life-threatening organ dysfunction caused by a deregulated immune host response to infection. The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has highlighted this multifactorial and complex syndrome. The absence of specific treatment neither against SARS-CoV-2 nor against acute respiratory distress syndrome (ARDS), the most serious stage of this infection, has emphasized the need to find alternative treatments. Several therapeutics are currently being tested, including mesenchymal stromal cells. These cells, already used in preclinical models of ARDS, sepsis, and septic shock and also in a few clinical trials, appear well-tolerated and promising, but many questions remain unanswered. Twit Text FOAVip Mesenchymal stromal cells for sepsis and septic shock: Lessons for treatment of COVID-19 ????Stem Cells Transl Med http://www.kidney.de/pget.php?&tw=1&pmid=32808462 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32808462 #FOAvip English Wikipedia <ref>{{Cite pmid|32808462}}</ref> Mesenchymal stromal cells for sepsis and septic shock: Lessons for treatment of COVID-19 #MMPMID32808462 Laroye C; Gibot S; Huselstein C; Bensoussan D Stem Cells Transl Med 2020[Dec]; 9 (12): 1488-1494 PMID32808462show ga Sepsis is defined as life-threatening organ dysfunction caused by a deregulated immune host response to infection. The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has highlighted this multifactorial and complex syndrome. The absence of specific treatment neither against SARS-CoV-2 nor against acute respiratory distress syndrome (ARDS), the most serious stage of this infection, has emphasized the need to find alternative treatments. Several therapeutics are currently being tested, including mesenchymal stromal cells. These cells, already used in preclinical models of ARDS, sepsis, and septic shock and also in a few clinical trials, appear well-tolerated and promising, but many questions remain unanswered. |*Mesenchymal Stem Cell Transplantation[MESH] |Animals[MESH] |COVID-19/pathology/*therapy/virology[MESH] |Clinical Trials as Topic[MESH] |Humans[MESH] |Mesenchymal Stem Cells/cytology/metabolism[MESH] |Respiratory Distress Syndrome/pathology/therapy[MESH] |SARS-CoV-2/isolation & purification[MESH] |Sepsis/pathology/*therapy[MESH] |Shock, Septic/pathology/*therapy[MESH]Mesenchymal stromal cells for sepsis and septic shock: Lessons for tre(epmc).pdf DeepDyve Pubget Overpricing